Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
04/28/1999 | EP0494268B2 Method for inhibiting growth of stem cells |
04/28/1999 | CN1215404A Non-dendritic backbone piptide carrier |
04/27/1999 | US5898067 Crystallization of proteins |
04/27/1999 | CA2064585C Inhibition of tumor growth by blockade of the protein c system |
04/27/1999 | CA2000345C Production of hydrolysed proteins |
04/22/1999 | WO1999019363A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
04/22/1999 | WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
04/22/1999 | WO1999019345A1 Method for purifying retroviral particles and soluble viral antigens |
04/22/1999 | WO1999019344A1 Coding combinatorial libraries with fluorine tags |
04/22/1999 | WO1999019343A1 Viral clearance process |
04/22/1999 | WO1999018945A1 Method of building and maintaining bone |
04/22/1999 | WO1999018856A1 Novel fluorescent reporter molecules and their applications including assays for caspases |
04/22/1999 | WO1998052917A3 Guanidinylation reagents |
04/22/1999 | CA2308125A1 Novel fluorescent reporter molecules and their applications including assays for caspases |
04/22/1999 | CA2306823A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
04/22/1999 | CA2306344A1 Method of building and maintaining bone |
04/22/1999 | CA2305771A1 Coding combinatorial libraries with fluorine tags |
04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
04/21/1999 | EP0909765A2 Calcitonin analogues having increased hypocalcaemic activity in vivo |
04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
04/21/1999 | EP0909272A1 Helicobacter pylori adhesin binding group antigen |
04/21/1999 | EP0909176A1 Reactor and method for solid phase peptide synthesis |
04/21/1999 | EP0808455B1 Application of countercurrent chromatography to the deconvolution of chemical libraries |
04/21/1999 | EP0565607B1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected |
04/21/1999 | CN1214691A Process for preparation of N-methyl-D-phenylalanyl-N-[1-[3-[(aminoiminomethyl)-amino] propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide |
04/21/1999 | CN1214689A Method of producing IGF-I and IGFBP-3 with correct folding and disulfide bonding |
04/20/1999 | US5895746 Immunoassay for detecting label bound to intact trimeric alpha1-homotrimeric peptide isolated without use of proteolytic enzymes |
04/20/1999 | CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
04/15/1999 | WO1999018440A1 Method of inferring three-dimensional structure of protein |
04/15/1999 | WO1999018240A2 Collections of uniquely tagged molecules |
04/15/1999 | WO1999018196A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
04/15/1999 | WO1999006440A8 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |
04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
04/15/1999 | DE19744549A1 Apparatus for organic solid phase synthesis |
04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
04/15/1999 | CA2305559A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
04/14/1999 | EP0908105A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof |
04/14/1999 | EP0907887A1 Engineering affinity ligands for macromolecules |
04/14/1999 | EP0907378A1 Concentrated antibody preparation |
04/14/1999 | EP0787140A4 Process for performing retro-aldol reaction |
04/14/1999 | EP0679659B1 Cathepsin-l-specific inhibitor polypeptide |
04/14/1999 | EP0643559B1 Diphtheria toxin receptor-binding region |
04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
04/13/1999 | CA2079584C Methods for trans-destabilization of specific proteins in vivo |
04/08/1999 | WO1999016893A2 Enzymatic modification |
04/08/1999 | WO1999016427A1 Active agent transport systems |
04/08/1999 | WO1999003488A3 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
04/08/1999 | CA2304951A1 Active agent transport systems |
04/07/1999 | EP0906951A2 Storage of materials |
04/07/1999 | EP0906918A2 Process for production of insulin precursors having correctly linked cystein bridges |
04/07/1999 | EP0906571A1 Labelling and selection of molecules |
04/07/1999 | EP0906448A1 Methods for the diagnosis and prognosis of cancer |
04/07/1999 | EP0906417A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
04/07/1999 | EP0906416A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them |
04/07/1999 | EP0906340A1 Purification of factor viii complex by immunoaffinity chromatography |
04/07/1999 | EP0906334A1 Auto-deconvoluting combinatorial libraries |
04/07/1999 | EP0906333A2 Substrates and inhibitors of proteolytic enzymes |
04/07/1999 | EP0811019B1 Synthesis of hydroxamic acid derivatives |
04/07/1999 | EP0734393B1 Method for purifying polypeptides |
04/07/1999 | EP0642579B1 Improved methods for the preparation of endotoxin-binding proteins |
04/07/1999 | CN1213378A Antitumor substance extracted from Grifola |
04/07/1999 | CN1213377A Method for purification of protein from protein containing solution |
04/07/1999 | CN1213376A Method for increased yields of crystallized protein by using solid adsorption material |
04/07/1999 | CN1213375A Crystallization of protein with sulphur salt |
04/07/1999 | CN1213326A Filtration of plasma mixtures using cellulose-based filter aids |
04/07/1999 | CN1042833C Process for preparing growth factor of human nerve by embryonic down or decidual |
04/06/1999 | US5892005 High molecular and low molecular fractions of von willebrand factor |
04/06/1999 | US5891995 Allowing conversion from stable form to labile form for cleavage of peptide from support under mild conditions after deprotection of amino acid side chains |
04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
04/06/1999 | US5891993 Template assembled synthetic protein |
04/06/1999 | US5891855 Contacting with cardiac glycoside |
04/06/1999 | US5891840 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis |
04/06/1999 | US5891737 Orthogonally protected trifunctional scaffolds for solid phase synthesis of peptidomimetic combinatorial library |
04/06/1999 | US5891671 Method for cleaving chimeric protein using processing enzyme |
04/06/1999 | US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
04/01/1999 | WO1999015130A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
04/01/1999 | WO1999015024A1 Sequential separation of whey proteins and formulations thereof |
04/01/1999 | WO1998054577A9 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
04/01/1999 | WO1998053407A9 Prediction of relative binding motifs of biologically active peptides and peptide mimetics |
03/31/1999 | EP0905519A1 A method for amino acid sequencing of protein or peptide from carboxy terminus thereof |
03/31/1999 | EP0905251A1 Expression of heterologous protein in yeast |
03/31/1999 | EP0905246A1 Cloning of chicken anaemia DNA |
03/31/1999 | EP0904541A1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
03/31/1999 | EP0904540A1 Methods for spatially-dispersed positionally-encoded combinatorial library synthesis |
03/31/1999 | EP0904398A1 Chemokine alpha 3 |
03/31/1999 | EP0904355A1 Method of activating denatured protein |
03/31/1999 | EP0904293A1 An interleukin-5 antagonist |
03/31/1999 | EP0904285A1 Cyclic adhesion inhibitors |
03/31/1999 | EP0904096A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
03/31/1999 | EP0904095A1 Chimeric isoprenoid synthases and uses thereof |
03/31/1999 | EP0743861A4 Radiolabeled annexins |
03/31/1999 | CN1212707A Prion-free collagen and collagen-derived products and implants for multiple biomedical applications, method of making thereof |
03/31/1999 | CN1212703A Chromatographic process for obtaining very pure cycloporin A and related cyclosporins |
03/31/1999 | CN1042733C Use of jackfruit seed agglutinin affinity chromatographic column |
03/30/1999 | US5889165 Photolabile nucleoside protecting groups |
03/30/1999 | US5889160 Human IL-2 receptor γ-chain molecule antibody |